Sandra Levy
ARTICLES BY THIS AUTHOR
- 8/18/2021
UNFI, RangeMe expand partnership
Retailers and emerging suppliers can facilitate purchase orders directly on UNFI’s Easy Options platform through RangeMe. - 8/18/2021
FDA OKs new indication for Jardiance
Jardiance is now FDA approved to reduce the risk of cardiovascular death plus hospitalization for heart failure in adults with heart failure with reduced ejection fraction. - 8/18/2021
Albertsons, Walmart partner with United Airlines on preflight COVID-19 testing
United Airlines customers can access 3,000 COVID-19 testing locations at Albertsons and Walmart via the airline's mobile app and website. - 8/17/2021
iA unveils new suite of solutions to transform pharmacy
Pharmacy Fulfillment by iA, SmartPod and iA Therapy Management Solutions, enabled by NEXiA, are three new tools from iA intended to enhance the pharmacist-patient relationship. - 8/17/2021
Pfizer/BioNTech, Moderna booster shot to be available in September
The plan calls for all Americans who received Pfizer/BioNTech and Moderna to obtain a third shot eight months after their second dose. - 8/17/2021
Teva wins appeal upholding 3 patents for Ajovy
Teva won a U.S. appeals court ruling that upheld three patents on its Ajovy migraine drug, though six other patents on the treatment were ruled invalid, according to a report. - 8/17/2021
Flu shots available at CVS Pharmacy, MinuteClinic
Flu shots are now available at all CVS Pharmacy and MinuteClinic locations across the country, as well as at select CVS Pharmacy in Target stores. - 8/16/2021
U.S. health officials expected to recommend 3rd COVID-19 vaccine booster
U.S. health experts are expected to recommend COVID-19 vaccine boosters for all Americans beginning eight months after they received their second dose of the vaccine, according to an AP report. - 8/16/2021
Zydus Cadila gets tentative FDA OK for lenalidomide
Zydus Cadila has received tentative approval from the Food and Drug Administration to market lenalidomide capsules in several dosage strengths. - 8/16/2021
Upsher-Smith launches generic Tegretol
The carbamazepine extended-release tablet had a market value of roughly $120 million for the 12 months ended June 2021, according to IQVIA.
